Your Location:Home>Browse special issues>Journal:Informatics and Artificial Intelligence for Holistic Integrative Oncology
Informatics and Artificial Intelligence for Holistic Integrative Oncology
Informatics and Artificial Intelligence for Holistic Integrative Oncology
  • The Paper

    Artificial intelligence and machine learning for hemorrhagic trauma care

    Henry T. Peng, M. Musaab Siddiqui, Shawn G. Rhind, Jing Zhang, Luis Teodoro da Luz, Andrew Beckett
    Vol. 10, Issue 5, Pages: 680-698(2023) DOI: 10.1186/s40779-023-00444-0
    Abstract:Artificial intelligence (AI), a branch of machine learning (ML) has been increasingly employed in the research of trauma in various aspects. Hemorrhage is the most common cause of trauma-related death. To better elucidate the current role of AI and contribute to future development of ML in trauma care, we conducted a review focused on the use of ML in the diagnosis or treatment strategy of traumatic hemorrhage. A literature search was carried out on PubMed and Google scholar. Titles and abstracts were screened and, if deemed appropriate, the full articles were reviewed. We included 89 studies in the review. These studies could be grouped into five areas: 1) prediction of outcomes; 2) risk assessment and injury severity for triage; 3) prediction of transfusions; 4) detection of hemorrhage; and 5) prediction of coagulopathy. Performance analysis of ML in comparison with current standards for trauma care showed that most studies demonstrated the benefits of ML models. However, most studies were retrospective, focused on prediction of mortality, and development of patient outcome scoring systems. Few studies performed model assessment via test datasets obtained from different sources. Prediction models for transfusions and coagulopathy have been developed, but none is in widespread use. AI-enabled ML-driven technology is becoming integral part of the whole course of trauma care. Comparison and application of ML algorithms using different datasets from initial training, testing and validation in prospective and randomized controlled trials are warranted for provision of decision support for individualized patient care as far forward as possible.  
    Keywords:Artificial intelligence;Hemorrhage;Machine learning;Trauma;injury  
    52
    |
    27
    |
    0
    citations on Dimensions.
    citations on Dimensions.
    <HTML>
    <L-PDF><Meta-XML>
    <Citation><Bulk Citation>
    Updated:2024-01-23

    Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling

    Yuan-Peng Zhang, Yuan-Peng Zhang, Xin-Yun Zhang, Yu-Ting Cheng, Bing Li, Xin-Zhi Teng, Jiang Zhang, Saikit Lam, Ta Zhou, Zong-Rui Ma, Jia-Bao Sheng, Victor C. W. Tam, Shara W. Y. Lee, Hong Ge, Jing Cai
    Vol. 11, Issue 1, Pages: 115-147(2024) DOI: 10.1186/s40779-023-00458-8
    Abstract:Modern medicine is reliant on various medical imaging technologies for non-invasively observing patients’ anatomy. However, the interpretation of medical images can be highly subjective and dependent on the expertise of clinicians. Moreover, some potentially useful quantitative information in medical images, especially that which is not visible to the naked eye, is often ignored during clinical practice. In contrast, radiomics performs high-throughput feature extraction from medical images, which enables quantitative analysis of medical images and prediction of various clinical endpoints. Studies have reported that radiomics exhibits promising performance in diagnosis and predicting treatment responses and prognosis, demonstrating its potential to be a non-invasive auxiliary tool for personalized medicine. However, radiomics remains in a developmental phase as numerous technical challenges have yet to be solved, especially in feature engineering and statistical modeling. In this review, we introduce the current utility of radiomics by summarizing research on its application in the diagnosis, prognosis, and prediction of treatment responses in patients with cancer. We focus on machine learning approaches, for feature extraction and selection during feature engineering and for imbalanced datasets and multi-modality fusion during statistical modeling. Furthermore, we introduce the stability, reproducibility, and interpretability of features, and the generalizability and interpretability of models. Finally, we offer possible solutions to current challenges in radiomics research.  
    Keywords:Artificial intelligence;Radiomics;Feature extraction;Feature selection;Modeling;Interpretability;Multimodalities;Head and neck cancer  
    95
    |
    29
    |
    0
    citations on Dimensions.
    citations on Dimensions.
    <HTML>
    <L-PDF><Meta-XML>
    <Citation><Bulk Citation>
    Updated:2025-12-13

    What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?

    Li-Tao Zhao, Zhen-Yu Liu, Wan-Fang Xie, Li-Zhi Shao, Jian Lu, Jie Tian, Jian-Gang Liu
    Vol. 11, Issue 2, Pages: 268-286(2024) DOI: 10.1186/s40779-023-00464-w
    Abstract:The present study aimed to explore the potential of artificial intelligence (AI) methodology based on magnetic resonance (MR) images to aid in the management of prostate cancer (PCa). To this end, we reviewed and summarized the studies comparing the diagnostic and predictive performance for PCa between AI and common clinical assessment methods based on MR images and/or clinical characteristics, thereby investigating whether AI methods are generally superior to common clinical assessment methods for the diagnosis and prediction fields of PCa. First, we found that, in the included studies of the present study, AI methods were generally equal to or better than the clinical assessment methods for the risk assessment of PCa, such as risk stratification of prostate lesions and the prediction of therapeutic outcomes or PCa progression. In particular, for the diagnosis of clinically significant PCa, the AI methods achieved a higher summary receiver operator characteristic curve (SROC-AUC) than that of the clinical assessment methods (0.87 vs. 0.82). For the prediction of adverse pathology, the AI methods also achieved a higher SROC-AUC than that of the clinical assessment methods (0.86 vs. 0.75). Second, as revealed by the radiomics quality score (RQS), the studies included in the present study presented a relatively high total average RQS of 15.2 (11.0–20.0). Further, the scores of the individual RQS elements implied that the AI models in these studies were constructed with relatively perfect and standard radiomics processes, but the exact generalizability and clinical practicality of the AI models should be further validated using higher levels of evidence, such as prospective studies and open-testing datasets.  
    Keywords:Clinically significant prostate cancer;Adverse pathology;Radiomics quality score;Artificial intelligence;magnetic resonance imaging  
    67
    |
    37
    |
    0
    citations on Dimensions.
    citations on Dimensions.
    <HTML>
    <L-PDF><Meta-XML>
    <Citation><Bulk Citation>
    Updated:2025-12-13

    From immunology to artificial intelligence: revolu-tionizing latent tuberculosis infection diagnosis with machine learning

    Lin-Sheng Li, Ling Yang, Li Zhuang, Zhao-Yang Ye, Wei-Guo Zhao, Wen-Ping Gong
    Vol. 11, Issue 5, Pages: 747-784(2024) DOI: 10.1186/s40779-023-00490-8
    Abstract:Latent tuberculosis infection (LTBI) has become a major source of active tuberculosis (ATB). Although the tuberculin skin test and interferon-gamma release assay can be used to diagnose LTBI, these methods can only differentiate infected individuals from healthy ones but cannot discriminate between LTBI and ATB. Thus, the diagnosis of LTBI faces many challenges, such as the lack of effective biomarkers from Mycobacterium tuberculosis (MTB) for distinguishing LTBI, the low diagnostic efficacy of biomarkers derived from the human host, and the absence of a gold standard to differentiate between LTBI and ATB. Sputum culture, as the gold standard for diagnosing tuberculosis, is time-consuming and cannot distinguish between ATB and LTBI. In this article, we review the pathogenesis of MTB and the immune mechanisms of the host in LTBI, including the innate and adaptive immune responses, multiple immune evasion mechanisms of MTB, and epigenetic regulation. Based on this knowledge, we summarize the current status and challenges in diagnosing LTBI and present the application of machine learning (ML) in LTBI diagnosis, as well as the advantages and limitations of ML in this context. Finally, we discuss the future development directions of ML applied to LTBI diagnosis.  
    Keywords:Tuberculosis (TB);Latent tuberculosis infection (LTBI);Machine learning (ML);Biomarkers;Differential diagnosis  
    55
    |
    21
    |
    0
    citations on Dimensions.
    citations on Dimensions.
    <HTML>
    <L-PDF><Meta-XML>
    <Citation><Bulk Citation>
    Updated:2025-12-13

    Antimicrobial resistance crisis: could artificial intelligence be the solution?

    Guang-Yu Liu, Dan Yu, Mei-Mei Fan, Xu Zhang, Ze-Yu Jin, Christoph Tang, Xiao-Fen Liu
    Vol. 12, Issue 1, Pages: 72-95(2025) DOI: 10.1186/s40779-024-00510-1
    Abstract:Antimicrobial resistance is a global public health threat, and the World Health Organization (WHO) has announced a priority list of the most threatening pathogens against which novel antibiotics need to be developed. The discovery and introduction of novel antibiotics are time-consuming and expensive. According to WHO’s report of antibacterial agents in clinical development, only 18 novel antibiotics have been approved since 2014. Therefore, novel antibiotics are critically needed. Artificial intelligence (AI) has been rapidly applied to drug development since its recent technical breakthrough and has dramatically improved the efficiency of the discovery of novel antibiotics. Here, we first summarized recently marketed novel antibiotics, and antibiotic candidates in clinical development. In addition, we systematically reviewed the involvement of AI in antibacterial drug development and utilization, including small molecules, antimicrobial peptides, phage therapy, essential oils, as well as resistance mechanism prediction, and antibiotic stewardship.  
    Keywords:antibiotic;Artificial intelligence (AI);Clinical development;Machine learning (ML);Antimicrobial peptide;Phage therapy;Antibiotic stewardship  
    54
    |
    27
    |
    0
    citations on Dimensions.
    citations on Dimensions.
    <HTML>
    <L-PDF><Meta-XML>
    <Citation><Bulk Citation>
    Updated:2025-02-24